Evidence map›Paper›PMID 27103068›Full record

ArticleStatistics in medicine2016

Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.

David S Robertson, A Toby Prevost, Jack Bowden

Abstract read
In one paragraph

Article in Statistics in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Point estimation following a two-stage group sequential trial.Statistical methods in medical research · 2023
    Article
  5. Review
  6. The benefits of covariate adjustment for adaptive multi-arm designs.Statistical methods in medical research · 2022
    Article
  7. Article
  8. Article
  9. Adaptive multiarm multistage clinical trials.Statistics in medicine · 2020
    Article
  10. Article
  11. Conditionally unbiased estimation in the normal setting with unknown variances.Communications in statistics: theory and methods · 2019
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David S RobertsonMRC Biostatistics Unit, Cambridge, U.K.
A Toby PrevostImperial College London, London, U.K.
Jack BowdenMRC Biostatistics Unit, Cambridge, U.K.

Funding

Medical Research Council MC_EX_MR/L012286/1Medical Research Council MC_UP_1302/2Medical Research Council MC_UU_12013/1Medical Research Council MC_UU_12013/9Medical Research Council MR/N501906/1
6 · The paper itself

Abstract

Seamless phase II/III clinical trials offer an efficient way to select an experimental treatment and perform confirmatory analysis within a single trial. However, combining the data from both stages in the final analysis can induce bias into the estimates of treatment effects. Methods for bias adjustment developed thus far have made restrictive assumptions about the design and selection rules followed. In order to address these shortcomings, we apply recent methodological advances to derive the uniformly minimum variance conditionally unbiased estimator for two-stage seamless phase II/III trials. Our framework allows for the precision of the treatment arm estimates to take arbitrary values, can be utilised for all treatments that are taken forward to phase III and is applicable when the decision to select or drop treatment arms is driven by a multiplicity-adjusted hypothesis testing procedure. © 2016 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd.

Indexed as

Clinical Trials, Phase II as TopicClinical Trials, Phase III as TopicResearch DesignBiasBiometryHumansadaptive seamless designsphase II/III clinical trialstreatment selectionuniformly minimum variance unbiased estimator

Identifiers

PMID27103068
PMCPMC5026174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.